Figure 1
From: Effects of ulinastatin and docetaxel on breast cancer invasion and expression of uPA, uPAR and ERK
Inhibition of ulinastatin and docetaxel on MDA-MB-231 and MCF-7 cell invasion. Shown are the absorptions at 570 nm of cells treated with ulinastatin, docetaxe and ulinastatin plus docetaxe for 24 hours, respectively, in the lower chambers of transwells. Treatment of cells with ulinastatin, docetaxe and ulinastatin plus docetaxe significantly inhibited MDA-MB-231(1a) and MCF-7 (1b) cell invasion.